References
- Martello JL, Pummer TL, Krenzelok EP. Cost minimization analysis comparing enteral N-acetylcysteine to intravenous acetylcysteine in the management of acute acetaminophen toxicity. Clin Toxicol 2010; 48:79–83.
- Cantrell L, Shah N, Anderson PO, Brinbaum K, Kearney T. Assessing the influence of acetadote on use of intravenous N-acetylcysteine for acetaminophen poisonings. Hosp Pharm 2009; 44:491–496.
- Woo OF, Mueller PD, Olson KR, Anderson IB, Kim SY. Shorter duration of oral N‐acetylcysteine therapy for acute acetaminophen overdose. Ann Emerg Med 2000; 35:363–368.
- Tsai CL, Chang WT, Weng TI, Fang CC, Walson PD. A patient-tailored N-acetylcysteine protocol for acute acetaminophen intoxication. Clin Ther 2005; 27:336–341.
- Betten D, Cantrell F, Thomas SC, Williams SR, Clark RF. A prospective evaluation of shortened course oral N-acetylcysteine for the treatment of acute acetaminophen poisoning. Ann Emerg Med 2007; 50:272–279.
- Betten D, Burner EE, Thomas SC, Tomaszewski C, Clark RF. A retrospective evaluation of shortened-duration oral N-acetylcysteine for the treatment of acetaminophen poisoning. J Med Toxicol 2009; 5:183–190.
- Kao LW, Kirk MA, Furbee RB, Mehta NH, Skinner JR, Brizendine EJ. What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning. Ann Emerg Med 2003; 42:741–750.
- Lavonas E, Beuhler M, Ford M, Kerns W, Rouse A, Tomaszewski C, Wittler M. Intravenous administration of N-acetylcysteine: oral and parenteral formulations are both acceptable. Ann Emerg Med 2005; 45:223–224.
- American Hospital Association. Hospital Charges Explained. Chicago: AHA; 2003:1–7.. http://www.aha.org/aha/content/2003/pdf/HospitalChargesExplained12803.pdf [accessed March 10, 2010].
- Dart R, Rumack BH. Patient-tailored acetylcysteine administration. Ann Emerg Med 2007; 50:280–281.